- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03199365
Tu Salud Si Cuenta Intervention in Increasing Physical Activity and Healthy Eating Among Latino Families
Tu Salud ¡Si Cuenta! Reaching Latino Family Dyads to Increase Physical Activity and Healthy Eating
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
PRIMARY OBJECTIVES:
I. Conduct formative research with adult Latino family dyads to assess the home environment and current behaviors, and identify perceived determinants of healthy eating and physical activity (PA) within the family context.
II. Adapt the "Tu Salud Si Cuenta" (TSSC) intervention to focus on increasing physical activity (PA) and healthy eating among adult Latino family dyads (TSSC-Family).
III. Evaluate the acceptability of intervention content, materials, and procedures with adult Latino family dyads.
OUTLINE:
FORMATIVE RESEARCH: To adapt the intervention, participants undergo immersive assessment over 3 hours which is conducted by research staff and involves examination of the home food and PA environments, objective and self-reported PA, nutritional intake, demographics and relevant psychosocial measures. Participants are also instructed to wear an accelerometer device to measure physical activity for up to 7 days and participate in in-depth interviews over 1.5 hours.
PRE-TESTING: Participants undergo two TSSC intervention sessions delivered at participants' homes by trained community health workers (CHWs) over 1.5 hours.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Texas
-
Houston, Texas, United States, 77030
- M D Anderson Cancer Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Self-reported Hispanic/Latino ethnicity
- Age 18-65 years
- Speak English or Spanish
- Physically able to engage in low-to-moderate PA
- Consumption of fewer than 5 servings of fruits and vegetables per day
- Valid home address in the Houston neighborhoods of Gulfton, the East End/Magnolia, or Near Northside, or adjacent neighborhoods
- Working telephone number
Exclusion Criteria:
1) Pregnancy at any point during the study period OR considering pregnancy during the study period
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Prevention (TSSC intervention)
Participants undergo two TSSC intervention sessions delivered at participants' homes by trained CHWs over 1.5 hours.
|
Undergo TSSC intervention sessions
Undergo TSSC intervention sessions
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Identification of perceived determinants of healthy eating and physical activity (PA) as determined by questionnaires and interviews
Time Frame: Up to 2 years
|
The appropriate summary statistics will be calculated for continuous and categorical variables along with corresponding liberal (i.e., 80%) confidence intervals where appropriate.
Boxplots, histograms, and other graphical displays will also be generated in order to describe the sample.
Descriptive information will be used to inform future trials aimed at testing the intervention.
|
Up to 2 years
|
Evaluate and adapt the "Tu Salud Si Cuenta" (TSSC/Your Health Matters!) intervention
Time Frame: Up to 2 years
|
Results from the formative research phase will inform the adaptation of the TSSC intervention to focus on dyadic collaboration and support.
In general, TSSC-Family is proposed as a 6-month intervention involving six monthly home visits by a community health worker (CHW) who will deliver the TSSC curricula (Fitness for Life and Nutritious Eating), adapted for the dyadic approach, using non-directive motivational techniques.
Participants will be instructed in standard behavioral skills such as self-monitoring, goal setting, problem solving, and relapse prevention.
|
Up to 2 years
|
Evaluate the acceptability of intervention content, materials, and procedures
Time Frame: Up to 2 years
|
The appropriate summary statistics will be calculated for continuous and categorical variables along with corresponding liberal (i.e., 80%) confidence intervals where appropriate.
Boxplots, histograms, and other graphical displays will also be generated in order to describe the sample.
Descriptive information will be used to inform future trials aimed at testing the intervention.
|
Up to 2 years
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Larkin Strong, M.D. Anderson Cancer Center
Publications and helpful links
Helpful Links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 2015-0735 (Other Identifier: M D Anderson Cancer Center)
- P30CA016672 (U.S. NIH Grant/Contract)
- NCI-2018-01136 (Registry Identifier: CTRP (Clinical Trial Reporting Program))
- R56HL128705 (U.S. NIH Grant/Contract)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Healthy Subject
-
Changchun GeneScience Pharmaceutical Co., Ltd.Completed
-
CelltrionCompletedHealthy SubjectKorea, Republic of
-
Ohio State University Comprehensive Cancer CenterNational Cancer Institute (NCI)Active, not recruiting
-
Staidson (Beijing) Biopharmaceuticals Co., LtdCompleted
-
GeneScience Pharmaceuticals Co., Ltd.Completed
-
Kyowa Kirin Co., Ltd.Completed
-
Ohio State University Comprehensive Cancer CenterActive, not recruitingHealthy SubjectUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI); Texas A&M UniversityCompletedHealthy SubjectUnited States
-
Whanin Pharmaceutical CompanyCompletedHealthy SubjectKorea, Republic of
-
NovoBliss Research Pvt LtdCompleted
Clinical Trials on Behavioral Dietary Intervention
-
Brown UniversityNational Cancer Institute (NCI)UnknownUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Brown UniversityNational Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Sidney Kimmel Cancer Center at Thomas Jefferson...CompletedBreast CarcinomaUnited States
-
Rush University Medical CenterUniversity of Chicago; National Institute on Aging (NIA); Advocate Hospital SystemRecruitingStroke | Dementia | Alzheimer Disease | Dementia, Vascular | Cognitive DeclineUnited States
-
Case Comprehensive Cancer CenterCompletedEndometrial Cancer | Weight ChangesUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedProstate CancerUnited States
-
Josephine Ford Cancer CenterNational Cancer Institute (NCI)UnknownUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedEndometrial CancerUnited States
-
Virginia Polytechnic Institute and State UniversityNational Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)Not yet recruitingAnatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8United States